Clinical trial
ALCAR Prophylaxis Study
NCT00225160 · Royal Free Hampstead NHS Trust, Other · Unknown status
Key facts
| NCT number | NCT00225160 |
|---|---|
| Title | ALCAR Prophylaxis Study |
| Official title | A Randomised Double Blinded Placebo Controlled Pilot Study to Evaluate the Safety and Efficacy of Acetyl L Carnitine in Combination With Antiretroviral Therapy for the Prevention of Distal Symmetric Polyneuropathy and Lipid Abnormalities in Treatment naïve HIV Infected Subjects |
| Lead sponsor | Royal Free Hampstead NHS Trust, Other |
| Collaborators | Bristol-Myers Squibb Industry Sigma-Tau Research, Inc. |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Distal Symmetric Polyneuropathy |
| Intervention type | Drug |
| Interventions | acetyl L-carnitine |
| Enrollment | 50 |
| Start date | Nov 1, 2003 |
| First posted | Sep 23, 2005 |
| Last update posted | Sep 18, 2008 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: